![Josiah Craver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josiah Craver
Director of Finance/CFO at
FAETH THERAPEUTICS, INC.
Net worth: - $ as of 30/05/2026
Profile
Josiah Craver currently works at Sensei Biotherapeutics, Inc., as SVP-Finance, Chief Financial & Accounting Officer from 2024.
Mr. Craver also formerly worked at Kala Bio, Inc., as Senior Vice President & Controller and Solid Biosciences, Inc., as Vice President-Finance in 2020.
Mr. Craver received his undergraduate degree and graduate degree from Stonehill College, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Josiah Craver active positions
| Companies | Position | Start |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Director of Finance/CFO | 16/09/2024 |
Former positions of Josiah Craver
| Companies | Position | End |
|---|---|---|
| SOLID BIOSCIENCES INC. | Comptroller/Controller/Auditor | 29/02/2020 |
| KALA BIO, INC. | Comptroller/Controller/Auditor | - |
Training of Josiah Craver
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
- Stock Market
- Insiders
- Josiah Craver
